Ontology highlight
ABSTRACT: Introduction
Prostate biopsy is a key diagnostic tool for prostate cancer and is often associated with physical, emotional, and social challenges. To enhance future multicenter trial designs for diagnostic precision, understanding patient-relevant outcomes is essential. Current evidence on patient-reported outcomes (PROMs) and patient-reported experience measures (PREMs) in the context of prostate biopsies remains limited, particularly regarding perioperative biopsychosocial impacts. This study aimed to explore patient-relevant factors, including concerns, side effect tolerance, and preferences, to inform future trials through patient and public involvement (PPI).Methodology
A prospective monocentric qualitative study was conducted with 12 male patients (mean age: 69.8 year
SUBMITTER: Halbich JG
PROVIDER: S-EPMC12667091 | biostudies-literature | 2025 Nov
REPOSITORIES: biostudies-literature